Skip to main content

Site notifications

Notice for SARS-CoV-2 rS(MVC-COV1901) (Grand Pacific CRO Australia)

Active ingredients
SARS-CoV-2 rS(MVC-COV1901)
Date of review outcome
Lapse date
Type
Provisional determination
Indication
For active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 12-17 years of age.
Therapeutic area
Infectious diseases

Help us improve the Therapeutic Goods Administration site